サマリー

コンパニオン診断薬の世界市場 2023-2027
コンパニオン診断薬市場は、2022-2027年に11,029.63百万米ドルの成長が予測され、予測期間中のCAGRは22.59%で減速すると予測されています。当レポートでは、コンパニオン診断薬市場について、市場規模、予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、個別化医療の利用拡大、業界コラボレーションの増加、ライフサイエンス分野への投資拡大が牽引しています。
Technavio社のコンパニオン診断市場は以下のように区分されています：
エンドユーザー別
- ライフサイエンス
- 医療機関
- その他
適応症別
- 腫瘍学
- 神経内科
- その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間におけるコンパニオン診断薬市場の成長を促進する主な要因の1つとして、乳がんの発生件数の増加を挙げている。また、癌治療のための製品承認の増加やプロモーション活動の重要性の高まりは、市場の大きな需要につながるであろう。
本レポートでは、コンパニオン診断薬市場について以下の領域をカバーしています：
- コンパニオン診断薬市場のサイジング
- コンパニオン診断薬市場予測
- コンパニオン診断薬市場の産業分析
本レポートでは、コンパニオン診断市場の主要ベンダーであるAbbott Laboratories、Abnova Corp.、Agilent Technologies Inc.、Amoy Diagnostics Co.Ltd.、ARUP Laboratories、Bayer AG、BioGenex Laboratories Inc.、bioMerieux SA、F. Hoffmann La Roche Ltd.、Guardant Health Inc.、Illumina Inc.、Invivoscribe Inc.、Liquid Biotech USA Inc.、Myriad Genetics Inc.、NG Biotech、QIAGEN NV、Quest Diagnostics Inc.、Siemens AG、Sysmex Corp.、Thermo Fisher Scientific Inc.などです。また、コンパニオン診断薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは企業が戦略を練り、来るべき成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/companion-diagnostics-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global companion diagnostics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global companion diagnostics market 2017 - 2021 ($ million)
o 4.2 End-user Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.3 Indication Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Life science - Market size and forecast 2022-2027
o Exhibit 34: Chart on Life science - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Life science - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Life science - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Life science - Year-over-year growth 2022-2027 (%)
o 6.4 Health centers - Market size and forecast 2022-2027
o Exhibit 38: Chart on Health centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Health centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Health centers - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Health centers - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Indication
o 7.1 Market segments
o Exhibit 48: Chart on Indication - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Indication - Market share 2022-2027 (%)
o 7.2 Comparison by Indication
o Exhibit 50: Chart on Comparison by Indication
o Exhibit 51: Data Table on Comparison by Indication
o 7.3 Oncology - Market size and forecast 2022-2027
o Exhibit 52: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Oncology - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
o 7.4 Neurology - Market size and forecast 2022-2027
o Exhibit 56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
o 7.5 Others - Market size and forecast 2022-2027
o Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Indication
o Exhibit 64: Market opportunity by Indication ($ million)
o Exhibit 65: Data Table on Market opportunity by Indication ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 France - Market size and forecast 2022-2027
o Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 115: Abbott Laboratories - Overview
o Exhibit 116: Abbott Laboratories - Business segments
o Exhibit 117: Abbott Laboratories - Key news
o Exhibit 118: Abbott Laboratories - Key offerings
o Exhibit 119: Abbott Laboratories - Segment focus
o 12.4 Abnova Corp.
o Exhibit 120: Abnova Corp. - Overview
o Exhibit 121: Abnova Corp. - Product / Service
o Exhibit 122: Abnova Corp. - Key offerings
o 12.5 Agilent Technologies Inc.
o Exhibit 123: Agilent Technologies Inc. - Overview
o Exhibit 124: Agilent Technologies Inc. - Business segments
o Exhibit 125: Agilent Technologies Inc. - Key offerings
o Exhibit 126: Agilent Technologies Inc. - Segment focus
o 12.6 Amoy Diagnostics Co. Ltd.
o Exhibit 127: Amoy Diagnostics Co. Ltd. - Overview
o Exhibit 128: Amoy Diagnostics Co. Ltd. - Product / Service
o Exhibit 129: Amoy Diagnostics Co. Ltd. - Key offerings
o 12.7 ARUP Laboratories
o Exhibit 130: ARUP Laboratories - Overview
o Exhibit 131: ARUP Laboratories - Product / Service
o Exhibit 132: ARUP Laboratories - Key offerings
o 12.8 Bayer AG
o Exhibit 133: Bayer AG - Overview
o Exhibit 134: Bayer AG - Business segments
o Exhibit 135: Bayer AG - Key news
o Exhibit 136: Bayer AG - Key offerings
o Exhibit 137: Bayer AG - Segment focus
o 12.9 BioGenex Laboratories Inc.
o Exhibit 138: BioGenex Laboratories Inc. - Overview
o Exhibit 139: BioGenex Laboratories Inc. - Product / Service
o Exhibit 140: BioGenex Laboratories Inc. - Key offerings
o 12.10 bioMerieux SA
o Exhibit 141: bioMerieux SA - Overview
o Exhibit 142: bioMerieux SA - Product / Service
o Exhibit 143: bioMerieux SA - Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 144: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 146: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus
o 12.12 Illumina Inc.
o Exhibit 149: Illumina Inc. - Overview
o Exhibit 150: Illumina Inc. - Business segments
o Exhibit 151: Illumina Inc. - Key news
o Exhibit 152: Illumina Inc. - Key offerings
o Exhibit 153: Illumina Inc. - Segment focus
o 12.13 Myriad Genetics Inc.
o Exhibit 154: Myriad Genetics Inc. - Overview
o Exhibit 155: Myriad Genetics Inc. - Product / Service
o Exhibit 156: Myriad Genetics Inc. - Key offerings
o 12.14 QIAGEN NV
o Exhibit 157: QIAGEN NV - Overview
o Exhibit 158: QIAGEN NV - Product / Service
o Exhibit 159: QIAGEN NV - Key news
o Exhibit 160: QIAGEN NV - Key offerings
o 12.15 Siemens AG
o Exhibit 161: Siemens AG - Overview
o Exhibit 162: Siemens AG - Business segments
o Exhibit 163: Siemens AG - Key news
o Exhibit 164: Siemens AG - Key offerings
o Exhibit 165: Siemens AG - Segment focus
o 12.16 Sysmex Corp.
o Exhibit 166: Sysmex Corp. - Overview
o Exhibit 167: Sysmex Corp. - Business segments
o Exhibit 168: Sysmex Corp. - Key offerings
o Exhibit 169: Sysmex Corp. - Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 170: Thermo Fisher Scientific Inc. - Overview
o Exhibit 171: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 172: Thermo Fisher Scientific Inc. - Key news
o Exhibit 173: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 174: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 175: Inclusions checklist
o Exhibit 176: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 177: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 178: Research methodology
o Exhibit 179: Validation techniques employed for market sizing
o Exhibit 180: Information sources
o 13.5 List of abbreviations
o Exhibit 181: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global companion diagnostics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Life science - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Life science - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Life science - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Life science - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Health centers - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Health centers - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Health centers - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Health centers - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Indication - Market share 2022-2027 (%)
Exhibits49: Data Table on Indication - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Indication
Exhibits51: Data Table on Comparison by Indication
Exhibits52: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Indication ($ million)
Exhibits65: Data Table on Market opportunity by Indication ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: Abnova Corp. - Overview
Exhibits121: Abnova Corp. - Product / Service
Exhibits122: Abnova Corp. - Key offerings
Exhibits123: Agilent Technologies Inc. - Overview
Exhibits124: Agilent Technologies Inc. - Business segments
Exhibits125: Agilent Technologies Inc. - Key offerings
Exhibits126: Agilent Technologies Inc. - Segment focus
Exhibits127: Amoy Diagnostics Co. Ltd. - Overview
Exhibits128: Amoy Diagnostics Co. Ltd. - Product / Service
Exhibits129: Amoy Diagnostics Co. Ltd. - Key offerings
Exhibits130: ARUP Laboratories - Overview
Exhibits131: ARUP Laboratories - Product / Service
Exhibits132: ARUP Laboratories - Key offerings
Exhibits133: Bayer AG - Overview
Exhibits134: Bayer AG - Business segments
Exhibits135: Bayer AG - Key news
Exhibits136: Bayer AG - Key offerings
Exhibits137: Bayer AG - Segment focus
Exhibits138: BioGenex Laboratories Inc. - Overview
Exhibits139: BioGenex Laboratories Inc. - Product / Service
Exhibits140: BioGenex Laboratories Inc. - Key offerings
Exhibits141: bioMerieux SA - Overview
Exhibits142: bioMerieux SA - Product / Service
Exhibits143: bioMerieux SA - Key offerings
Exhibits144: F. Hoffmann La Roche Ltd. - Overview
Exhibits145: F. Hoffmann La Roche Ltd. - Business segments
Exhibits146: F. Hoffmann La Roche Ltd. - Key news
Exhibits147: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits148: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits149: Illumina Inc. - Overview
Exhibits150: Illumina Inc. - Business segments
Exhibits151: Illumina Inc. - Key news
Exhibits152: Illumina Inc. - Key offerings
Exhibits153: Illumina Inc. - Segment focus
Exhibits154: Myriad Genetics Inc. - Overview
Exhibits155: Myriad Genetics Inc. - Product / Service
Exhibits156: Myriad Genetics Inc. - Key offerings
Exhibits157: QIAGEN NV - Overview
Exhibits158: QIAGEN NV - Product / Service
Exhibits159: QIAGEN NV - Key news
Exhibits160: QIAGEN NV - Key offerings
Exhibits161: Siemens AG - Overview
Exhibits162: Siemens AG - Business segments
Exhibits163: Siemens AG - Key news
Exhibits164: Siemens AG - Key offerings
Exhibits165: Siemens AG - Segment focus
Exhibits166: Sysmex Corp. - Overview
Exhibits167: Sysmex Corp. - Business segments
Exhibits168: Sysmex Corp. - Key offerings
Exhibits169: Sysmex Corp. - Segment focus
Exhibits170: Thermo Fisher Scientific Inc. - Overview
Exhibits171: Thermo Fisher Scientific Inc. - Business segments
Exhibits172: Thermo Fisher Scientific Inc. - Key news
Exhibits173: Thermo Fisher Scientific Inc. - Key offerings
Exhibits174: Thermo Fisher Scientific Inc. - Segment focus
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations